Latest posts tagged with #ISLB24 on Bluesky
Amazing #ISLB24 congress in summary:
303 participants,
24 countries 🌎
100 abstracts 📝
50 speakers 👨🏫👩🏫
26 travel awards ✈️
3 ISLB awards🥇
32 sponsors
5 satellite symposium ✏️
THAKS ALL OF YOU “THE” INTERNATIONAL LIQUID BIOPSY SOCIETY IS GROWING EVERY YEAR ! @isliquidbiopsy
🌟 A growing society, a brighter future!
📍 Denver welcomed 303 delegates from 24 countries, 100 abstracts, and 76 posters at #ISLB24.
See you in Orlando for #ISLB25!
#LiquidBiopsy #Oncology #PrecisionMedicine
@christianrolfo.bsky.social
@rolfolab.bsky.social
@oncoalert.bsky.social
It has been an amazing #ISLB24 congress!! More than 300 participants from 24 countries around the globe 🌎 50 speakers and more than 100 abstracts with 24 travel grants. Great discussions! Thanks to participants, speakers, sponsors & @ICS_Events ! See you in Orlando #ISLB25 !
@GianniNigita from @osucccjames.bsky.social @rolfolab.bsky.social presenting the minimal requirements for bioinformatics in analyzing liquid biopsy data at #ISLB24
More complex data —> more power bioinformatics required! 💻🤖
@christianrolfo.bsky.social @UmbertoMalapel1 @isliquidbiopsy
One of the best slides of #ISLB24! Molecular testing transforms cancer care—from early detection to resistance mechanisms in metastatic disease. Precision at every stage.
@drgandara
@christianrolfo.bsky.social @oncoalert.bsky.social
Honored to have @lillian_siu elected president of @AACR at the #ISLB24 meeting talking about HPV ctDNA!
HPV genotyping in plasma may be the future!
Truly inspiring 💪🏻🔥🎯
@isliquidbiopsy
@christianrolfo.bsky.social
@christianrolfo.bsky.social
@UmbertoMalapel1
High ctDNA tumor fraction boosts confidence in driver-negative reports, while low ctDNA suggests need for confirmatory tissue testing.
#LiquidBiopsy #Oncology #PrecisionMedicine #ISLB24
@christianrolfo.bsky.social @oncoalert.bsky.social
Great panel discussion on the session about early cancer detection at #ISLB24
So many options and ideas for cancer research! 🎯🔍
@christianrolfo.bsky.social
#JacobBerchuck
#trevorPugh
#martaDuenas
@internationalsocietyofliquidbiopsy
@christianrolfo.bsky.social presenting at #ISLB24 early detection strategies for different cancers!
📚Many studies are being published in this topic
What is the best strategy?
—>a mix of different technologies 👨🏻🔬👩🔬 + AI integration! 🤖
@isliquidbiopsy
@OSUCCC_James
Second day at #ISLB24 with @christianrolfo.bsky.social presenting data on early cancer detection in different cancer types!
—> is possible but there are many different LB 🩸 method that must be integrated with AI 🤖
@internationalsocietyofliquidbiopsy
@ohiostatepress.bsky.social
ISLB committees are tirelessly working to shape a better future for patients and society. Advancing innovation and collaboration in liquid biopsy!
#LiquidBiopsy #Oncology #PrecisionMedicine #ISLB24 @christianrolfo.bsky.social @oncoalert.bsky.social
🏆Award session and inspiring Award lectures!
#LuisDiaz #EllenHeltzer #DennisLo
#ISLB24
@isliquidbiopsy @christianrolfo.bsky.social @MJOSESERRANO19
🎯 @BrunaPellini just explained to me how their algorithm could help in distinguishing between variants identified via LB “truly/potentially” targetable vs CH-derived across different tumor types
⚡️ Great energy here! @isliquidbiopsy
#ISLB24
Luis Diaz’s award lecture emphasized liquid biopsy’s role in precision medicine: biomarkers, tumor monitoring, resistance tracking, and early detection.
#LiquidBiopsy #Oncology #ISLB24 @christianrolfo.bsky.social
@oncoalert.bsky.social
❔❓Having expert to discuss key questions in liquid biopsy!
This is #ISLB24
@isliquidbiopsy @christianrolfo.bsky.social
#abhijitPatel #pazVellanki #murryWynes #davidkozono #lucaQuagliata #adamSowalsky
Great job by @Rparedes_MD presenting our poster on “ctDNA as marker for Brain Metastasis at Diagnosis and During Treatment” at #ISLB24 @rolfolab
@isliquidbiopsy @OhioStateMedOnc @OSUCCC_James @IcahnMountSinai @TischCancer
LB - Tissue
Detection of gene copy number (CN) losses (PTEN, BRCA1/2, PALB2) in prostate, breast and ovarian cancer.
--> High concordance (liquid/tissue) in samples with Tumor Fraction ≥ 20% (sensitivity 83%)
#ISLB24
@christianrolfo.bsky.social
@internationalsocietyofliquidbiopsy
Super poster session! 🧨
@UmbertoMalapel1
shows us how an algorithm can filter out genomic alterations while analyzing LB sample in a prostate cancer cohort of patients!
#ISLB24
@isliquidbiopsyx.com/RobertoBoreaMD/status/18...
Collaboration and innovation at #ISLB24! Connecting with brilliant minds to advance the field of #LiquidBiopsy and #PrecisionMedicine. Together, we push boundaries.
@oncoalert.bsky.social
@christianrolfo.bsky.social
At #ISLB24 release of the new @oncoindx multiomics machine on Live Single CTCs combining genomic profiling with CTC DNA and ctDNA 🧬
@christianrolfo.bsky.social
Terrific presentation of @christianrolfo.bsky.social from @OSUCCC_James on tumor fraction detection and calculation in cfDNA! 🧬
—> we must implement cfDNA fraction analysis to improve the comprehension of LB
#ISLB24
@internationalsocietyofliquidbiopsy
@UmbertoMalapel1 @stoverlab.bsky.social
Can we trust negative ctDNA results? @christianrolfo.bsky.social
🧬🩸Data from #ISLB24 highlights the prognostic value of tumor fraction in ctDNA.
🧬🩸Tumor fraction ≥1% correlates strongly with actionable findings, while low TF (<1%) often requires tissue-based confirmation for accuracy.
Great presentation from @natashaleighl from @pmargaretcancercenter on the usage of molecular testing in cancer patients!
🥵 Hot topics:
- timing ⏱️
- patient point of view 🫵
- type of test 🤷🏻♀️
- cost 💰
#ISLB24
Liquid biopsies improve testing rates, reduce delays, and guide optimal treatment in advanced lung cancer. Making it routine is the next big step. #ISLB24
#LiquidBiopsy #Oncology
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social
LB 🩸 isn’t only for medical oncologist!
@aadel_chaudhuri from @MayoClinic is sharing data on the use of LB MRD during and after radiotherapy treatment with great results in predicting patient outcome!
#ISLB24
@christianrolfo.bsky.social @rolfolab.bsky.social
@isliquidbiopsy
We are all genetic mosaics! Clonal mosaicism is the rule, not the exception. A fascinating insight into our cellular diversity at #ISLB24.
#LiquidBiopsy #Oncology
@christianrolfo.bsky.social
@rolfolab.bsky.social
@oncoalert.bsky.social
cfDNA analysis is a cornerstone of precision oncology. Serial liquid biopsies hold promise for urothelial and prostate cancers. Future directions shared at #ISLB24.
#LiquidBiopsy #Oncology
@christianrolfo.bsky.social
@oncoalert.bsky.social
Nice to meet great international colleagues/researchers at #ISLB24! 🌎
Ready for this great event to share knowledge about liquid biopsy! 🔥
@internationalsocietyofnliquidbiopsy
@christianrolfo.bsky.social
@umbertomalapelle
@brunapellini
@robertoboreamd.bsky.social
@mariantonianacchio
David R. Gandara discusses recent applications of ctDNA in early-stage NSCLC at #ISLB24. Liquid biopsy is transforming precision treatment strategies.
🩸🧬Is MRD testing ready for routine use?
#LiquidBiopsy #Oncology
@christianrolfo.bsky.social
@oncoalert.bsky.social
20 years of advancements in circulating tumor cells. From discovery to clinical utility in solid tumors, transforming breast cancer management at #ISLB24.
#LiquidBiopsy #Oncology @christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social
